Evidence map›Paper›PMID 29423271›Full record

ArticleCell discovery2018

Dual roles of endothelial FGF-2-FGFR1-PDGF-BB and perivascular FGF-2-FGFR2-PDGFRβ signaling pathways in tumor vascular remodeling.

Kayoko Hosaka, Yunlong Yang, Masaki Nakamura, Patrik Andersson, Xiaojuan Yang, Yin Zhang, Takahiro Seki, Martin Scherzer, Olivier Dubey, Xinsheng Wang and 1 more

Open access · goldAbstract read
In one paragraph

Article in Cell discovery, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 63 citations in OpenAlex.

  1. Review
  2. Article
  3. Mechanisms of Pericyte-Mediated Cancer Metastasis.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Kayoko Hosaka1Department of Microbiology, Tumor and Cell Biology, Karolinska Institute, Stockholm, 171 77 Sweden.
Yunlong Yang1Department of Microbiology, Tumor and Cell Biology, Karolinska Institute, Stockholm, 171 77 Sweden.
Masaki Nakamura1Department of Microbiology, Tumor and Cell Biology, Karolinska Institute, Stockholm, 171 77 Sweden.
Patrik Andersson1Department of Microbiology, Tumor and Cell Biology, Karolinska Institute, Stockholm, 171 77 Sweden.
Xiaojuan Yang1Department of Microbiology, Tumor and Cell Biology, Karolinska Institute, Stockholm, 171 77 Sweden.
Yin Zhang1Department of Microbiology, Tumor and Cell Biology, Karolinska Institute, Stockholm, 171 77 Sweden.
Takahiro Seki1Department of Microbiology, Tumor and Cell Biology, Karolinska Institute, Stockholm, 171 77 Sweden.
Martin Scherzer1Department of Microbiology, Tumor and Cell Biology, Karolinska Institute, Stockholm, 171 77 Sweden.
Olivier Dubey1Department of Microbiology, Tumor and Cell Biology, Karolinska Institute, Stockholm, 171 77 Sweden.
Xinsheng Wang2Central Research Laboratory, The Affiliated Hospital of Qingdao University, Qingdao, 266071 China.
Yihai Cao1Department of Microbiology, Tumor and Cell Biology, Karolinska Institute, Stockholm, 171 77 Sweden.
Karolinska Institutet · SEAffiliated Hospital of Qingdao University · CNQingdao University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Perivascular cells are important cellular components in the tumor microenvironment (TME) and they modulate vascular integrity, remodeling, stability, and functions. Here we show using mice models that FGF-2 is a potent pericyte-stimulating factor in tumors. Mechanistically, FGF-2 binds to FGFR2 to stimulate pericyte proliferation and orchestrates the PDGFRβ signaling for vascular recruitment. FGF-2 sensitizes the PDGFRβ signaling through increasing PDGFRβ levels in pericytes. To ensure activation of PDGFRβ, the FGF-2-FGFR1-siganling induces PDGF-BB and PDGF-DD, two ligands for PDGFRβ, in angiogenic endothelial cells. Thus, FGF-2 directly and indirectly stimulates pericyte proliferation and recruitment by modulating the PDGF-PDGFRβ signaling. Our study identifies a novel mechanism by which the FGF-2 and PDGF-BB collaboratively modulate perivascular cell coverage in tumor vessels, thus providing mechanistic insights of pericyte-endothelial cell interactions in TME and conceptual implications for treatment of cancers and other diseases by targeting the FGF-2-FGFR-pericyte axis.

Identifiers

PMID29423271
PMCPMC5798893
OpenAlexW2782716256

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.